Assignee profile:

ImmusanT, Inc.

City:

Cambridge, Massachusetts

Country:

United States

Published Applications:

19

Last publication date:

2021-04-22

Patent Grants:

5

Last grant date:

2019-11-12

Top Inventors for applications by ImmusanT, Inc.

These are the the leading inventors for applications assigned to ImmusanT, Inc.:

Recent patent applications by ImmusanT, Inc.

ImmusanT, Inc. based in Cambridge, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-04-22
US20210115096A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE

#2 | 2020-12-24
US20200397852A1
Human necessities

DOSING REGIMENS FOR CELIAC DISEASE

#3 | 2020-05-07
US20200141924A1
Physics

PEPTIDES FOR USE IN TREATMENT AND DIAGNOSIS OF TYPE 1 DIABETES

#4 | 2020-01-23
US20200024664A1
Chemistry; metallurgy

USE OF HLA GENETIC STATUS TO ASSESS OR SELECT TREATMENT OF CELIAC DISEASE

#5 | 2019-11-12 ✅ Patent 10,473,647 granted on 2019-11-12
US15528172
Physics

Peptides for use in treatment and diagnosis of type 1 diabetes

#6 | 2019-07-25
US20190224276A1
Human necessities

ESCALATING DOSAGE SCHEDULES FOR TREATING CELIAC DISEASE

#7 | 2019-07-04
US20190204341A1
Physics

COMPOSITIONS AND METHODS FOR DIAGNOSING CELIAC DISEASE USING CIRCULATING CYTOKINES/CHEMOKINES

#8 | 2019-02-14
US20190048047A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE

#9 | 2017-08-17
US20170232083A1
Human necessities

METHODS OF DIAGNOSIS AND TREATMENT OF CELIAC DISEASE IN CHILDREN

#10 | 2017-08-03 ✅ Patent 10,370,718 granted on 2019-08-06
US20170218453A1
Chemistry; metallurgy

Use of HLA genetic status to assess or select treatment of celiac disease

#11 | 2017-06-08
US20170158743A1
Chemistry; metallurgy

COMPOSITIONS AND METHODS FOR TREATMENT OF CELIAC DISEASE

#12 | 2017-04-06
US20170097346A1
Physics

USE OF INTERLEUKIN-2 FOR DIAGNOSIS OF CELIAC DISEASE

#13 | 2017-03-02
US20170059582A1
Physics

METHODS FOR DIAGNOSING CELIAC DISEASE USING CIRCULATING CYTOKINES/CHEMOKINES

#14 | 2017-02-16
US20170045529A1
Physics

METHODS OF MEASURING ANTIGEN-SPECIFIC T CELLS

#15 | 2017-02-16
US20170045513A1
Physics

METHODS OF DIAGNOSING CELIAC DISEASE USING IP-10

#16 | 2017-02-16
US20170042991A1
Human necessities

COMPOSITIONS COMPRISING GLUTEN PEPTIDES AND USES THEREOF

#17 | 2016-08-04 ✅ Patent 10,449,228 granted on 2019-10-22
US20160220629A1
Human necessities

Dosage of a gluten peptide composition

#18 | 2015-02-19 ✅ Patent 9,464,120 granted on 2016-10-11
US20150050303A1
Chemistry; metallurgy

Compositions for treatment of celiac disease

#19 | 2011-12-01 ✅ Patent 8,835,603 granted on 2014-09-16
US20110293644A1
Chemistry; metallurgy

Agents for the treatment of celiac disease

Also check out ImmusanT, Inc.'s (Cambridge, United States) applicant profile with 4 patent applications submitted.

AssigneeID:

88095 ⎘